One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials.

被引：1

作者：

Muramatsu, Takashi ^{[1
]}

Onuma, Yoshinobu ^{[2
]}

Van Geuns, Robert J. ^{[3
]}

Chevalier, Bernard ^{[4
]}

Patel, Tejas M. ^{[5
]}

Seth, Ashok ^{[6
]}

Diletti, Roberto ^{[2
]}

Garcia-Garcia, Hector M. ^{[1
]}

Dorange, Cecile ^{[7
]}

Veldhof, Susan ^{[7
]}

Cheong, Wai-Fung ^{[8
]}

Whitbourn, Robert J. ^{[9
]}

Bartorelli, Antonio L. ^{[10
]}

Abizaid, Alexandre ^{[11
]}

Serruys, Patrick W. ^{[2
]}

机构：

[1] Erasmus MC, Thoraxctr, Rotterdam, Netherlands

[2] Erasmus Univ, Thoraxctr, NL-3000 DR Rotterdam, Netherlands

[3] Erasmus MC, Rotterdam, Netherlands

[4] ICPS, Massy, France

[5] Apex Heart Inst, Ahmadabad, Gujarat, India

[6] Fortis Escorts Heart Inst, New Delhi 110025, India

[7] Abott Vasc Int BVBA, Diegem, Belgium

[8] Abbott Vasc, Santa Clara, CA USA

[9] St Vincents Hosp, Melbourne, Vic, Australia

[10] Univ Milan, Milan, Italy

[11] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2013年 / 62卷 / 18期

关键词：

D O I：

10.1016/j.jacc.2013.08.766

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

下载

页码：B12 / B13

页数：2

共 50 条

[1] One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic scents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials
Costa, Jose de Ribamar, Jr.
Abizaid, Alexandre
Bartorelli, Antonio L.
Whitbourn, Robert
Jepson, Nigel
Perin, Marco
Steinwender, Clemens
Stuteville, Marrianne
Ediebah, Divine
Sudhir, Krishnankutty
Serruys, Patrick W.
EUROINTERVENTION, 2016, 12 (10) : 1255 - 1262
[2] Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial
Ribamar Costa, J., Jr.
Abizaid, Alexandre
Whitbourn, Robert
Serruys, Patrick W.
Jepson, Nigel
Steinwender, Clemens
Stuteville, Marrianne
Ediebah, Divine
Sudhir, Krishnankutty
Bartorelli, Antonio L.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (01) : E1 - E7
[3] Diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: Clinical outcomes of a subgroup analysis from an all-comers absorb registry
Camacho Freire, Santiago J.
Roa-Garrido, Jessica
Gomez Menchero, Antonio
Cardenal, Rosa M.
Leon Jimenez, Javier
Gomez Fernandez, Prudencia
Landero Garcia, Francisco J.
Diaz Fernandez, Jose F.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B211 - B212
[4] LONG-TERM OUTCOMES OF PATIENTS TREATED WITH EVEROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLDS VERSUS EVEROLIMUS-ELUTING METALLIC STENTS: A PROPENSITY SCORE COMPARISON OF PATIENTS ENROLLED IN THE ABSORB EXTEND AND SPIRIT TRIALS
Costa, Jose de Ribamar
Abizaid, Alexandre
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 430 - 430
[5] 1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds
Muramatsu, Takashi
Onuma, Yoshinobu
van Geuns, Robert-Jan
Chevalier, Bernard
Patel, Tejas M.
Seth, Ashok
Diletti, Roberto
Garcia-Garcia, Hector M.
Dorange, Cecile C.
Veldhof, Susan
Cheong, Wai-Fung
Ozaki, Yukio
Whitbourn, Robert
Bartorelli, Antonio
Stone, Gregg W.
Abizaid, Alexandre
Serruys, Patrick W.
JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (05) : 482 - 493
[6] 3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds The ABSORB III Trial
Kereiakes, Dean J.
Ellis, Stephen G.
Metzger, Christopher
Caputo, Ronald P.
Rizik, David G.
Teirstein, Paul S.
Litt, Marc R.
Kini, Annapoorna
Kabour, Ameer
Marx, Steven O.
Popma, Jeffrey J.
McGreevy, Robert
Zhang, Zhen
Simonton, Charles
Stone, Gregg W.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (23) : 2852 - 2862
[7] ABSORB Cohort B Trial: Two Year Clinical and Angiographic Results of the ABSORB Bioresorbable Everolimus Eluting Vascular Scaffold
Ormiston, Jhon
Serruys, Patrick W.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B66 - B66
[8] Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials
Campos, Carlos M.
Caixeta, Adriano
Franken, Marcelo
Bartorelli, Antonio L.
Whitbourn, Robert J.
Wu, Chiung-Jen
Kao, Hsien Li Paul
Ali, Rosli Mohd
Carrie, Didier
De Bruyne, Bernard
Stone, Gregg W.
Serruys, Patrick W.
Abizaid, Alexandre
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 (03) : 387 - 395
[9] Risk and timing of clinical events according to diabetic status of patients treated with Everolimus-Eluting Bioresorbable Vascular Scaffolds vs. Everolimus-Eluting stent: 2-Year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials
Campos, Carlos
Abizaid, Alexandre
Caixeta, Adriano
Bartorelli, Antonio
Whitbourn, Robert
Perin, Marco
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B167 - B167
[10] Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial
Serruys, Patrick
Chevalier, Bernard
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B27 - B27

← 1 2 3 4 5 →